Balchem (BCPC) EPS (Weighted Average and Diluted) (2016 - 2025)
Balchem (BCPC) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $1.21 as the latest value for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) rose 17.48% to $1.21 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.75, a 20.87% increase, with the full-year FY2025 number at $4.75, up 361.17% from a year prior.
- EPS (Weighted Average and Diluted) was $1.21 for Q4 2025 at Balchem, down from $1.24 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.24 in Q3 2025 to a low of $0.66 in Q4 2022.
- A 5-year average of $0.91 and a median of $0.9 in 2022 define the central range for EPS (Weighted Average and Diluted).
- Peak YoY movement for EPS (Weighted Average and Diluted): soared 31.43% in 2022, then decreased 21.35% in 2023.
- Balchem's EPS (Weighted Average and Diluted) stood at $0.76 in 2021, then fell by 13.16% to $0.66 in 2022, then increased by 25.76% to $0.83 in 2023, then grew by 24.1% to $1.03 in 2024, then grew by 17.48% to $1.21 in 2025.
- Per Business Quant, the three most recent readings for BCPC's EPS (Weighted Average and Diluted) are $1.21 (Q4 2025), $1.24 (Q3 2025), and $1.17 (Q2 2025).